)
)
Lantern Pharma Investor Relations Material
Latest events
Q3 2024
Lantern Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Lantern Pharma Inc
Access all reports
Lantern Pharma is a clinical stage biotechnology company whose clinical programs target patients that have limited or poor options. Lantern's revolutionary AI platform, RADR®, uses leading edge machine learning techniques to help optimize drug development and clinical trial design, identify potential new indications for approved drugs, and improve the success of oncology clinical trials.
Key slides for Lantern Pharma Inc
Q2 2024
Lantern Pharma Inc
Q4 2023
Lantern Pharma Inc
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
LTRN
Country
🇺🇸 United States